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Abstract
Background:  Toll-like receptor 4 (TLR4) is essential in lipopolysaccharide (LPS)-induced
fibroblast activation and collagen secretion in vitro. However, its effects on the process of lung
fibroblast activation and fibrosis initiation during LPS induced acute lung injury (ALI) remain
unknown. The goal of the present study was to determine the effect of inhibiting TLR4 on LPS-
induced ALI and fibrosis in vivo.
Methods: The ALI model was established by intraperitoneal injection of LPS in mice. TLR4-small
hairpin RNA (shRNA) lentivirus was injected intravenously into the mice to inhibit TLR4
expression. mRNA and protein levels were detected by real-time PCR and Western-blot analysis,
respectively. The contents of the C-terminal propeptide of type I procollagen (PICP) in
bronchoalveolar lavage fluid (BALF) were detected by ELISA, and the degree of fibrosis was
detected by van Gieson collagen staining, the hydroxyproline assay, and alpha smooth muscle actin
(α-SMA) immunohistochemical staining.
Results: Overexpression of TLR4, type I procollagen, alpha-SMA, and p-AKT in murine pulmonary
tissue after intraperitoneal injection of LPS at 72 hours and 28 days were detected. Moreover, the
degree of fibrosis was shown to increase by ELISA analysis of PICP in BALF, van Gieson collagen
staining, the hydroxyproline assay, and α-SMA immunohistochemical staining. All of these changes
were alleviated by intravenous infection with TLR4-shRNA lentivirus.
Conclusions: Inhibiting TLR4 signaling could ameliorate fibrosis at the early stage of ALI induced
by LPS.
Background
Lipopolysaccharides (LPSs), which constitute the princi-
pal endotoxin of Gram-negative bacteria, are important
factors in acute lung injury (ALI). Although ALI tradition-
ally was considered to progress through successive stages
of exudation, proliferation, and fibrosis, The process of
fibrosis recently was found to be initiated during the early
stage of ALI[1]. Toll-like receptor 4 (TLR4) is a widely dis-
tributed LPS receptor in lung tissue. The role of TLR4 in
infectious and even non-infectious induced fibrosis has
aroused increasing concern[2,3].
LPSs exert their biological effects through TLR4. LPSs pro-
mote TLR4 expression in the mononuclear phagocytic sys-
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tem and promote the secretion of pro-fibrotic cytokines,
including transforming growth factor-β1 (TGF-β1).
Through a series of direct and indirect pathways, LPSs
stimulate lung fibroblast proliferation and alpha smooth
muscle actin (α-SMA) expression and differentiate lung
fibroblasts into myofibroblasts to synthesize and secrete
collagen. The carboxyterminal propeptide of type I pro-
collagen (PICP) is a marker of type I collagen synthesis
and is closely related to ALI prognosis[4]. LPS stimulation
results in the deposition of extracellular matrix (ECM)
and eventually diffuses interstitial pulmonary fibrosis[5].
LPSs, by inducing the paracrine action of some inflamma-
tory factors, induce lung fibroblast chemotaxis, activate
pulmonary macrophages, and work together with other
cells during the pulmonary fibrosis process[6,7]. TLR4
also is expressed in lung fibroblasts. Our preliminary stud-
ies illustrated that LPSs could activate the
phosphoinositide3-kinase-Akt (PI3K-Akt) pathway via
TLR4 in primary cultured mouse lung fibroblasts, which
subsequently promoted the synthesis of α-SMA and the
activation of fibroblasts, thereby directly promoting colla-
gen secretion and accelerating the process of pulmonary
fibrosis through the upregulation of integrin β1 expres-
sion[8].
Because TLR4 is a key point in the first step of the LPS sig-
nal transduction pathway, inhibiting TLR4 expression and
the subsequent blocking of its signal pathway may repre-
sent an effective way to ameliorate the acute inflammatory
reaction and pulmonary fibrosis that occur during ALI. In
vitro research found that inhibiting TLR4 can alleviate the
LPS-induced inflammatory reaction during the early
stages of ALI[9]. However, the effects of inhibiting TLR4
expression at the tissue level on the process of lung fibrob-
last activation and fibrosis initiation remain unknown.
In this study, we used the lentivirus-mediated RNA inter-
ference technique to inhibit TLR4 gene expression in
mouse lung tissue in order to observe lung fibroblasts acti-
vation, pulmonary fibrosis initiation, and progression
during LPS-induced ALI. We also investigated the role that
inhibiting TLR4 plays in ameliorating LPS-induced ALI
and fibrosis.
Methods
Animals
The experiment was performed using 8-week-old male
C57BL/6 mice obtained from the Shanghai SLAC Labora-
tory Animal Co. Ltd. They were allowed free access to
water and commercial rodent chow and were housed in
pathogen-free cages. This study was approved by Shanghai
Jiaotong University School of Medicine Animal Care and
Use Committee. All procedures were performed in accord-
ance with the guidelines of the National Institutes of
Health for animal care[10].
Small hairpin RNA (shRNA) lentivirus vector of the TLR4 
gene
pGCL-GFP-lentivirus expressing small hairpin RNAs (shR-
NAs) targeting the TLR4 gene (hereafter called TLR4-
shRNA lentivirus) and negative control lentivirus express-
ing non-targeting sequence were bought from Shanghai
Genechem Co. Ltd. (Shanghai, China).
Forty-eight hours after infecting mice with TLR4-shRNA
lentivirus via intravenous injection, TLR4-shRNA lentivi-
rus could infect both parenchymal and marrow-derived
cells in mice lung tissue with high efficiency. It could inte-
grate into the genome of host cells and exhibit stable
expression for more than 28 days.
Experimental design
Intraperitoneal injection of LPSs in mice can establish a
model of acute lung injury[11]. In this study, 60 mice
were randomly divided into five groups (n = 12):
• Blank control group (Group BC): Physiological
saline was administered intraperitoneally without len-
tivirus infection or LPS stimulation.
￿ Negative control group (Group NC): These animals
were infected with negative control shRNA lentivirus,
without LPS stimulation.
￿ Positive control group (Group PC): These animals
were infected with negative control shRNA lentivirus
and stimulated with LPS.
￿ TLR4 inhibition group (Group TI): Animals in this
group were infected with TLR4-shRNA lentivirus with-
out LPS stimulation.
￿ TLR4 inhibition group stimulated with LPS (Group
TI+L): Animals in this group were infected with TLR4-
shRNA lentivirus and then stimulated with LPS.
In groups TI and TI+L, 5 × 107 TU/ml of TLR4-shRNA len-
tivirus were injected intravenously into the mice to inhibit
TLR4 mRNA expression; the same dose of negative control
shRNA lentivirus was applied in groups NC and PC. In
groups PC and TI+L, 5 mg/kg LPS (serotype O55: B5;
Sigma Chemical, Taufkirchen, Germany) from Escherichia
coli were injected intraperitoneally for 3 consecutive days
48 hours after lentivirus infection to induce endotoxemia
and pulmonary fibrosis. The same volume of physiologi-
cal saline was injected in the same way in group BC, NC,
and TI to serve as a control.
After LPS (or physiological saline) administration, each
group was subdivided into two subgroups labeled "3d"
(72 hours after LPS or physiological saline administra-Respiratory Research 2009, 10:126 http://respiratory-research.com/content/10/1/126
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tion) and "4w" (4 weeks after LPS or physiological saline
administration). Thus, the experiment consisted of 10
groups, each containing 6 mice. The mice were monitored
on a daily basis for 72 hours (early period of ALI) or 28
days (later period of ALI) after LPS administration. At the
appropriate time, the mice were euthanized with intra-
peritoneal injection of pentobarbital (120 mg/kg), fol-
lowed by exsanguination by closed intracardiac puncture.
Lung tissues were quickly removed and processed as
described below.
Bronchoalveolar lavage (BAL) and measurement of PICP 
by ELISA
BAL was conducted for the measurement of PICP in bron-
choalveolar lavage fluid (BALF) as described else-
where[12]. BAL fluid was centrifuged, and the supernatant
was used for the measurement of PICP by ELISA[4].
Histopathological examination
Lung tissue excised 72 hours or 28 days after LPS applica-
tion was subjected to hematoxylin-eosin (HE) and van
Gieson (VG) staining to detect inflammation or collagen
deposition during ALI. The severity of fibrosis was
assessed semiquantitatively using the Ashcroft score:
Grade 0, normal lung; Grade 1, minimal fibrous thicken-
ing of alveolar or bronchiolar walls; Grade 3, moderate
thickening of walls without obvious damage to the lung
architecture; Grade 5, increased fibrous with definite dam-
age to the lung architecture and formation of fibrous
bands or small fibrous masses; Grade 7, severe distortion
of the architecture and a large fibrous area; Grade 8, total
fibrous obliteration of the field[13]. All of the sections
were evaluated and scored independently by two investi-
gators in a blinded manner. Severity of fibrotic changes in
each lung section was assessed as the mean score for sever-
ity from the observed microscopic fields.
Hydroxyproline assay in lung tissue
Pulmonary collagen secretion and deposition 28 days
after application of LPS in mice were quantitatively ana-
lyzed using the hydroxyproline assay. The samples were
hydrolyzed with 6 N HCl at 110°C for 18 hours following
Woessner's method[14]. After neutralization with NaOH,
the hydrolyzates were diluted with distilled water.
Hydroxyproline in the hydrolyzates was assessed colori-
metrically at 550 nm for the presence of p-dimethylami-
nobenzaldehyde. Results were expressed as micrograms of
hydroxyproline per lung.
Real-time PCR
The mRNA expression levels of type I procollagen, TLR4,
integrin β1, and α-SMA were analyzed using a real-time
PCR quantification method. Housekeeping gene actin was
used as a control. Total RNA was isolated from tissue with
the RNeasy kit (Trizol, Invitrogen, USA) and then reverse-
transcribed into cDNA with a reverse transcription kit (M-
MLV, Promega, USA). Sequence-specific primers were
designed as follows: Actin-F: 5'-TGCGTGACATCAAAGA-
GAAGC-3', Actin-R: 5'-CAGCACTGTGTTGGCATAGAG-
3'; TLR4-F: 5'-ATGGCATGGCTTACACCACC-3', TLR4-R:
5'-GAGGCCAATTTTGTCTCCACA-3'; integrin β1-F: 5'-
TAAACCTCTGGGCTTCACTG-3', integrin β1-R: 5'-
TGTCTTCACTGTTCACTTCATC-3';  α-SMA-F: 5'-
CTGCCGAGCGTGAGATTG-3',  α-SMA-R: 5'-ATAGGT-
GGTTTCGTGGATGC-3'; type I procollagen-F: 5'-TGA-
GACAGGCGAACAAGG-3', type I procollagen-R: 5'-
CAGGAGAACCAGCAGAGC-3'. Real-time PCR was per-
formed on the IQ5 PCR System (Bio-Rad, USA) with an
initial denaturing step at 95°C for 15 seconds, 45 denatur-
ing cycles at 95°C for 5 seconds, and an annealing step at
60°C for 30 seconds. Relative expression of real-time PCR
products was determined by using the ΔΔCt method[15]
to compare target and housekeeping gene expression.
Western blot analysis
Protein levels of TLR4, integrin β1, α-SMA, and Akt phos-
phorylation products (p-AKT) in each group were
detected by Western blot analysis. Tissues were collected
and lysed with protease inhibitor in 1 × lysis buffer on ice
for 10 to 15 minutes. Samples were centrifuged and super-
natants were collected. Protein quantification was per-
formed using the BCA method, and SDS-PAGE
electrophoresis was performed. Proteins were transferred
to PVDF membranes and detected using the ECL+plusTM
Western blotting system kit (Amersham, USA). Primary
antibody (TLR4 from Santa Cruz, p-Akt from CST, α-SMA
and integrin β1 from Abcam) was diluted to 1:1000 in this
experiment. Data were analyzed by gel imaging systems
and corrected using β-actin as the internal control.
Immunohistochemistry
To determine α-SMA expression in lung tissue, paraffin-
embedded tissue was processed using the avidin-biotin
immunoperoxidase method. The antibody against α-SMA
(Abcam, 1:100) was used for immunohistochemistry. All
of the sections were evaluated and scored independently
by two investigators in a blinded manner.
Statistical methods
All data were represented as mean ± standard deviation,
and SPSS12.0 software (SPSS, Inc., USA) was used for sta-
tistical analysis. The homogeneity of variance data were
analyzed with the one-way analysis of variance LSD test
and the heterogeneity of variance data were analyzed with
the Kruskal Wallis rank sum test. Statistical significance
was defined at P < 0.05.Respiratory Research 2009, 10:126 http://respiratory-research.com/content/10/1/126
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Results
TLR4-mediated pulmonary fibrosis induced by LPS
First, we determined the role of TLR4 in the activation of
lung fibroblasts and collagen secretion at the tissue level.
As shown in Figure 1, HE and VG staining of lung tissue
stimulated with LPS revealed that 72 hours after the LPS
challenge, the lung tissue showed obvious inflammatory
reactions, and typical interstitial fibrosis occurred 28 days
after LPS challenge. At the same time, the Ashcroft score
increased significantly compared with the blank and neg-
ative control groups (P < 0.05).
PICP is a segment of type I procollagen degraded from the
C-terminal by the procollagen C-endopeptidase, and it is
Inflammation and fibrosis in mouse lung tissue after LPS challenge Figure 1
Inflammation and fibrosis in mouse lung tissue after LPS challenge. (A) The pathological changes in mouse lung tissue 
72 hours and 28 days after intraperitoneal injection of LPS were observed by means of HE staining (HE, A, magnification ×200). 
Pulmonary fibrosis was observed by means of Van-Gieson staining (VG, magnification ×200). (B) The Ashcroft fibrosis score 
was used to compare the degrees of the pulmonary fibrosis 28 days after application of LPS in mice. The mice showed obvious 
inflammatory reactions in lung tissue 72 hours after LPS challenge. Typical pulmonary interstitial fibrosis appeared 4 weeks 
later. Infection with TLR4-shRNA lentivirus significantly inhibited the inflammatory reaction and fibrosis induced by LPS. BC: 
blank control group; NC: negative control group; PC: positive control group; TI: TLR4 inhibition group; TI+L: TLR4 inhibition 
group stimulated with LPS; 3d: specimens were collected 72 hours after LPS (or physiological saline) challenge. 4w: specimens 
were collected 28 days after LPS (or physiological saline) challenge. Each subgroup contains 6 specimens respectively (n = 6). 
Results were expressed as mean ± standard deviation indicated with column graph and error bar. Statistical significance was 
defined at p values < 0.05. *: P < 0.05 versus PC.Respiratory Research 2009, 10:126 http://respiratory-research.com/content/10/1/126
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closely related to ALI prognosis[4]. It has been investi-
gated in a number of lung diseases as a marker of type I
collagen synthesis[16]. The ELISA results showed that the
content of PICP in mouse BALF increased significantly 72
hours after LPS challenge (i.e., at the early stage of ALI)
(Figure 2A). Furthermore, at the late stage of ALI (28 days
after LPS challenge), the hydroxyproline assay demon-
strated that the content of hydroxyproline, a marker of
collagen synthesis, in mouse lung tissue was significantly
higher than that in the blank and the negative control
groups (P < 0.05) (Figure 2B). Real-time PCR and Western
blot analyses showed that upregulation of type I procolla-
gen and α-SMA, a marker of fibroblast activation,
appeared 72 hours after LPS challenge and became inten-
sive 4 weeks later (Figure 2C, 2D). Immunohistochemical
staining for α-SMA also illustrated α-SMA upregulation in
the PC group (Figure 3).
The expression of TLR4 in lung tissue also increased signif-
icantly 72 hours after LPS challenge, as detected by real-
time PCR and Western blot analysis (P < 0.05) (Figure 2C,
2D). However, infection with TLR4-shRNA lentivirus
inhibited TLR4 expression at the mRNA and protein levels
(Figure 2C, 2D, Figure 3), downregulated the content of
PICP in mouse BALF (Figure 2A) and hydroxyproline (Fig-
ure 2B), inhibited the expression of α-SMA and type I pro-
collagen (Figure 2C, 2D, Figure 3), and therefore
alleviated the degree of pulmonary fibrosis induced by
LPS (Figure 1). However, TLR4-shRNA lentivirus treat-
ment could not completely inhibit PICP (Figure 2A),
hydroxyproline (Figure 2B), α-SMA, and type I procolla-
gen (Figure 2C, 2D, 3) expression, as shown by the com-
parison between the TI and TI+L groups.
LPS activates the PI3K-Akt pathway via TLR4 and 
upregulated integrin β1 expression
Our preliminary studies showed that LPS could activate
the PI3K-Akt pathway via TLR4 in primary cultured mouse
lung fibroblasts. Herein, we examined the molecular
mechanism of this pathway at the tissue level. Real-time
PCR and Western blot analysis showed that the Akt phos-
phorylation levels, which indicate the activation of the
PI3K-Akt pathway, and integrin β1 expression were signif-
icantly increased 72 hours after LPS challenge and became
intensive 4 weeks later compared with the blank and neg-
ative control groups (P < 0.05) (Figure 4). These changes
could be inhibited by infection with the TLR4-shRNA len-
tivirus, but TLR4-shRNA lentivirus could not completely
inhibit p-AKT and integrin β1 expression.
Discussion
Although it has long been known that an inflammatory
reaction accompanies fibrosis diseases[17], the mecha-
nism that underlies the interaction of the two processes
remains unclear. Past reports of TLR4 expression in lung
tissue after LPS challenge have been controversial [2,18-
21], possibly because of differing experimental designs
and because organisms can initiate different regulatory
mechanisms depending on physiopathologic state
[19,22-24]. Our experimental results showed that the
expression of TLR4 in mice lung tissue increased consist-
ently 3 days and 28 days after LPS challenge, which was
consistent with data from some previous reports
[2,20,21,24]. These results suggest that some positive
feedback mechanism, such as crosstalk between different
intracellular signal transduction pathways of various
receptors, may exist and continue to affect the expression
of TLR4. Furthermore, as the overexpression of TLR4 in
lung tissue was accompanied by the aggravation of fibro-
sis, it is reasonable, based on our previous in vitro study,
to speculate that the LPS challenge could induce the over-
expression of TLR4 in mice lung fibroblasts, thereby
enhancing their sensitivity to LPS and activating lung
fibroblasts to initiate the progress of pulmonary fibrosis.
α-SMA is a marker of fibroblast activation and its presence
indicates the occurrence of fibroblast transition towards
myofibroblast. Myofibroblasts can synthesize and secrete
collagen to the ECM and thereby lead to pulmonary inter-
stitial fibrosis. PICP is a segment of type I procollagen that
is degraded from the C-terminal by the procollagen C-
endopeptidase, and it is closely related to ALI progno-
sis[4]. It has been investigated in a number of lung dis-
eases as a marker of type I collagen synthesis[16]. Our
results illustrated the positive effects of TLR4 inhibition in
preventing the inflammatory reaction and fibrosis in ALI
induced by LPS in vitro[8]. In this experiment, the expres-
sion of TLR4 in mouse lung tissue increased significantly
72 hours after LPS treatment and was accompanied by
increased expression of α-SMA, type I procollagen, and
PICP; moreover, the degree of pulmonary fibrosis became
intense 4 weeks after LPS challenge (Figures 1, 2, 3). This
result indicates that LPS can upregulate TLR4 expression
and activate lung fibroblasts after TLR4 activation at the
early inflammatory reaction stage of ALI, thereby promot-
ing collagen synthesis and secretion and causing pulmo-
nary interstitial fibrosis. Macrophage recruitment and the
proinflammatory response to Mycobacterium tuberculosis
are impaired in TLR4 mutant mice, resulting in chronic
infection and impaired elimination of mycobacteria.
Therefore, TLR4 signaling is required to mount a protec-
tive response during chronic infection[25]. Because
genetic mutation of TLR4 resulted in impairment of the
development of protective immunity, in the present study
we used the lentiviral shRNA infection approach to specif-
ically reduce TLR4 expression in mice and studied the
effects of suppression of TLR4 expression on lung tissue
after LPS challenge. This approach overcomes the short-
comings of traditional plasmid transfection, in which the
transfection efficiency for the primary culture cells is tooRespiratory Research 2009, 10:126 http://respiratory-research.com/content/10/1/126
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Collagen synthesis and secretion in mouse lung tissue after LPS challenge Figure 2
Collagen synthesis and secretion in mouse lung tissue after LPS challenge. (A) ELISA was used to detect PICP con-
tents in mouse BALF to compare the synthesis of pulmonary type I collagen 72 hours after intraperitoneal injection of LPS. (B) 
Pulmonary collagen secretion and deposition 28 days after application of LPS in mice were quantitatively analyzed with hydrox-
yproline assay. (C) The mRNA expression of type I procollagen, α-SMA, and TLR4 in mouse lung tissue was detected by real-
time PCR. (D) Protein expression of α-SMA and TLR4 were detected using Western blots. Type I procollagen, α-SMA, and 
TLR4 expression in mouse lung tissue increased significantly 72 hours after LPS challenge and become intensive 4 weeks later. 
Infection with TLR4-shRNA lentivirus significantly inhibited these changes. BC: blank control group; NC: negative control 
group; PC: positive control group; TI: TLR4 inhibition group; TI+L: TLR4 inhibition group stimulated with LPS; 3d: specimens 
were collected 72 hours after LPS (or physiological saline) challenge. 4w: specimens were collected 28 days after LPS (or phys-
iological saline) challenge. Each subgroup contains 6 specimens respectively (n = 6). Results were expressed as mean ± stand-
ard deviation indicated with column graph and error bar. Blots were representative of six separate experiments. Statistical 
significance was defined at p values < 0.05. *: P < 0.05 versus PC; **:P < 0.05 versus TI.Respiratory Research 2009, 10:126 http://respiratory-research.com/content/10/1/126
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low and the duration of expression in the host is too short.
Therefore, this technique may be a useful gene therapy
approach for treating pulmonary fibrosis during ALI.
TLR4-shRNA lentivirus infection may inhibit the expres-
sion of α-SMA and type I procollagen (Figure 2C, 2D, 3)
and therefore alleviate the degrees of pulmonary fibrosis
induced by LPS (Figure 1).
Integrin exerts a dual regulatory function to accelerate the
inflammatory reaction and the development of pulmo-
nary interstitial fibrosis[26,27]. PI3K is a converging point
for multiple signal transduction pathways and can be acti-
vated by different signals, including integrins, TGF-β1,
and insulin-like growth factor-1 (IGF-1)[26,28,29]. The
PI3K-Akt pathway is involved in α-SMA expres-
sion,[30,31] TGF-β-mediated cytokine release, and upreg-
ulation of integrin expression,[29,32] thereby playing a
critical role in the development of fibrosis diseases. Our
previous in vitro study showed that the PI3K-Akt pathway
could promote LPS-induced fibroblast activation and col-
lagen secretion as part of the TLR4-mediated signal trans-
duction pathway in lung fibroblast[8]. In this experiment,
mouse lung tissue showed increased integrin β1 expres-
sion and Akt phosphorylation levels 72 hours after LPS
challenge. However, infection with TLR4-shRNA lentivi-
rus could inhibit both the LPS-induced upregulation of
integrin β1 and Akt phosphorylation, suggesting that LPS
plays these roles through the PI3K-AKT pathway via TLR4
(Figure 4). It would be more clinically relevant if the PI3k/
AKT pathway had been inhibited pharmacologically in
animals with an intact TLR4 receptor; such a finding
would prove its importance in the development of fibro-
sis. This experiment will be conducted in the future.
Although our work and previous studies have shown the
positive effects of TLR4 inhibition in preventing the
inflammatory reaction and fibrosis in ALI induced by
endotoxins of a Gram-negative bacillus,[9] it was also
reported in non-Gram-negative bacteria[22,25,33] or
even non-infectious factors[34] induced ALI animal mod-
els, the absence or inhibition of TLR4 expression could
lead to aggravation of inflammatory injury and increased
animal mortality. This suggests that as a pathogen pattern
recognition receptor, TLR4 has a protective effect in regu-
lating cellular immune function, maintaining the stability
of alveolar epithelium, and reconstruction after inflam-
matory reaction. However, excessive expression and acti-
vation of TLR4 in certain pathological states may result in
uncontrolled inflammatory responses and fibrosis. There-
fore, the regulatory mechanisms of TLR4 expression in dif-
ferent pathological states and the means to prevent the
overexpression of TLR4 are important directions for fur-
ther study.
Infection with TLR4-shRNA lentivirus could not com-
pletely inhibit PICP (Figure 2A), hydroxyproline (Figure
2B), α-SMA, and type I procollagen (Figure 2C, 2D, Figure
3) expression and also could not completely inhibit p-
AKT and integrin β1 expression (Figure 4) (as shown by
the comparison between the TI and TI+L group). Thus,
fibrosis induced by LPS is not completely blocked by TLR4
inhibition. This result suggests that TLR4 is not the only
Expression of α-SMA in mouse lung tissue after LPS challenge Figure 3
Expression of α-SMA in mouse lung tissue after LPS challenge. Paraffin-embedded mouse lung tissue samples were 
deparaffinized, rehydrated, and processed to detect α-SMA using the avidin-biotin immunoperoxidase method. Representative 
images (×200) of samples are shown. BC: blank control group; NC: negative control group; PC: positive control group; TI: 
TLR4 inhibition group; TI+L: TLR4 inhibition group stimulated with LPS; 3d: specimens were collected 72 hours after LPS (or 
physiological saline) challenge. 4w: specimens were collected 28 days after LPS (or physiological saline) challenge. Each sub-
group contains 6 specimens respectively (n = 6).Respiratory Research 2009, 10:126 http://respiratory-research.com/content/10/1/126
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Activation of the PI3K-Akt pathway and expression of integrin β1 in mouse lung tissue after LPS challenge Figure 4
Activation of the PI3K-Akt pathway and expression of integrin β1 in mouse lung tissue after LPS challenge. The 
p-AKT or integrin β1 in mouse lung tissue was detected by real-time PCR (A) or Western blot (B). P-Akt, which reflected Akt 
phosphorylation levels, and integrin β1 expression increased significantly 72 hours after LPS challenge and become intensive 4 
weeks later. Infection with TLR4-shRNA lentivirus significantly inhibited these changes. BC: blank control group; NC: negative 
control group; PC: positive control group; TI: TLR4 inhibition group; TI+L: TLR4 inhibition group stimulated with LPS; 3d: 
specimens were collected 72 hours after LPS (or physiological saline) challenge. 4w: specimens were collected 28 days after 
LPS (or physiological saline) challenge. Each subgroup contains 6 specimens respectively (n = 6). Results were expressed as 
mean ± standard deviation indicated with column graph and error bar. Blots were representative of six separate experiments. 
Statistical significance was defined at p values < 0.05. *: P < 0.05 versus PC; **:P < 0.05 versus TI.Respiratory Research 2009, 10:126 http://respiratory-research.com/content/10/1/126
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activator of the PI3K-Akt pathway and the resulting fibro-
sis. The residual protein expression may represent the acti-
vation of different pathways. Activators of the PI3K-Akt
pathway, such as integrins, TGF-β1, and IGF-1[26,28,29],
should be studied further.
Conclusions
In this experiment, we used an in vivo experiment to show
that TLR4 could activate the PI3K-Akt pathway and upreg-
ulate expression of integrin β1, thereby promoting fibrob-
last activation and collagen secretion and initiating
pulmonary fibrosis at the early stage of ALI. Inhibiting
TLR4 expression by transfection with the TLR4-shRNA
lentivirus inhibited the process of fibrosis at the early
stage of ALI. Thus, this treatment might decrease the sever-
ity of LPS-induced ALI and pulmonary fibrosis and subse-
quently improve the prognosis of the disease.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
ZhengYu He performed the experimental studies and
drafted the manuscript. YeSen Zhu designed and planned
the experiments and assisted with several phases of the
study. Hong Jiang designed the experimental set up,
supervised the experimental work, participated in the
manuscript preparation and contributed important intel-
lectual content. All authors have read and approved the
final manuscript.
Acknowledgements
This research was supported by Science and Technology Commission of 
Shanghai Municipality (No. 07ZR14069). We thank Dr.Luying Zheng and 
Dr.Donglai Yang for pathology assistance.
References
1. Marshall RP, Bellingan G, Webb S, Puddicombe A, Goldsack N, McAn-
ulty RJ, Laurent GJ: Fibroproliferation occurs early in the acute
respiratory distress syndrome and impacts on outcome.
American journal of respiratory and critical care medicine 2000,
162(5):1783-1788.
2. Janardhan KS, McIsaac M, Fowlie J, Shrivastav A, Caldwell S, Sharma
RK, Singh B: Toll like receptor-4 expression in lipopolysaccha-
ride induced lung inflammation.  Histology and histopathology
2006, 21(7):687-696.
3. Yoshizaki A, Iwata Y, Komura K, Ogawa F, Hara T, Muroi E, Takenaka
M, Shimizu K, Hasegawa M, Fujimoto M, et al.: CD19 regulates skin
and lung fibrosis via Toll-like receptor signaling in a model of
bleomycin-induced scleroderma.  The American journal of pathol-
ogy 2008, 172(6):1650-1663.
4. Armstrong L, Thickett DR, Mansell JP, Ionescu M, Hoyle E, Billing-
hurst RC, Poole AR, Millar AB: Changes in collagen turnover in
early acute respiratory distress syndrome.  American journal of
respiratory and critical care medicine 1999, 160(6):1910-1915.
5. Olman MA, White KE, Ware LB, Simmons WL, Benveniste EN, Zhu
S, Pugin J, Matthay MA: Pulmonary edema fluid from patients
with early lung injury stimulates fibroblast proliferation
through IL-1 beta-induced IL-6 expression.  J Immunol 2004,
172(4):2668-2677.
6. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner
DA, Schwabe RF: TLR4 enhances TGF-beta signaling and
hepatic fibrosis.  Nature medicine 2007, 13(11):1324-1332.
7. Vancheri C, Crimi N, Conte E, Pistorio MP, Mastruzzo C, Lamicela M,
Messina A, Mistretta A: Human lung fibroblasts inhibit tumor
necrosis factor-alpha production by LPS-activated mono-
cytes.  American journal of respiratory cell and molecular biology 1996,
15(4):460-466.
8. He Z, Zhu Y, Jiang H: Toll-like receptor 4 mediates lipopolysac-
charide-induced collagen secretion by phosphoinositide3-
kinase-Akt pathway in fibroblasts during acute lung injury.
Journal of receptor and signal transduction research 2009, 29(2):119-125.
9. Knuefermann P, Wrigge H, Putensen C, Hoeft A, Grohe C, Baumgar-
ten G: Role of toll-like receptor 4 in the pathogenesis of LPS-
induced acute lung injury.  Intensive Care Medicine 2003, 29:S5-S.
10. Guide for the core and use of laboratory animals.  National
Academy Press; 1985. 
11. Wang XQ, Zhou Y, Zhou X: The roles of glucocorticoid and glu-
coorticoid receptor in the pulmonary fibrosis caused by
acute lung injury induced by lipopolysaccharide in rats.  Chi-
nese Journal of Respiratory and Critical Care Medicine 2007,
6(5):332-343.
12. Betsuyaku T, Fukuda Y, Parks WC, Shipley JM, Senior RM: Gelati-
nase B is required for alveolar bronchiolization after intrat-
racheal bleomycin.  The American journal of pathology 2000,
157(2):525-535.
13. Ashcroft T, Simpson JM, Timbrell V: Simple method of estimating
severity of pulmonary fibrosis on a numerical scale.  Journal of
clinical pathology 1988, 41(4):467-470.
14. Woessner JF Jr: The determination of hydroxyproline in tissue
and protein samples containing small proportions of this
imino acid.  Archives of biochemistry and biophysics 1961, 93:440-447.
15. Meijerink J, Mandigers C, Locht L van de, Tonnissen E, Goodsaid F,
Raemaekers J: A novel method to compensate for different
amplification efficiencies between patient DNA samples in
quantitative real-time PCR.  J Mol Diagn 2001, 3(2):55-61.
16. Lammi L, Ryhanen L, Lakari E, Risteli J, Paakko P, Kahlos K, Lahde S,
Kinnula V: Type III and type I procollagen markers in fibrosing
alveolitis.  American journal of respiratory and critical care medicine
1999, 159(3):818-823.
17. Luckey SW, Petersen DR: Activation of Kupffer cells during the
course of carbon tetrachloride-induced liver injury and fibro-
sis in rats.  Experimental and molecular pathology 2001,
71(3):226-240.
18. Baumgarten G, Knuefermann P, Wrigge H, Putensen C, Stapel H, Fink
K, Meyer R, Hoeft A, Grohe C: Role of Toll-like receptor 4 for
the pathogenesis of acute lung injury in Gram-negative sep-
sis.  Eur J Anaesthesiol 2006, 23(12):1041-1048.
19. Fan J, Kapus A, Marsden PA, Li YH, Oreopoulos G, Marshall JC, Frantz
S, Kelly RA, Medzhitov R, Rotstein OD: Regulation of Toll-like
receptor 4 expression in the lung following hemorrhagic
shock and lipopolysaccharide.  J Immunol 2002,
168(10):5252-5259.
20. Ma L, Li WD, Chen WM: The Effect of Propofol on Toll-like
Receptor 4 Expression in the Rat Lung Tissues of LPS-
induced Acute Lung Injury.  Journal of China Medical University
2009, 38(4):261-264.
21. Wu YW, Bai M, Zhang JC, Jin Y, Zhang L, Bao B: [The effect of
nitric oxide inhalation on the expression of COX-2 and toll-
like receptor 4 in rat acute lung injury induced by lipopoly-
saccharide].  Zhonghua Jie He He Hu Xi Za Zhi 2009, 32(2):111-114.
22. Monick MM, Yarovinsky TO, Powers LS, Butler NS, Carter AB, Gud-
mundsson G, Hunninghake GW: Respiratory syncytial virus up-
regulates TLR4 and sensitizes airway epithelial cells to endo-
toxin.  The Journal of biological chemistry 2003, 278(52):53035-53044.
23. Lv TF, Shen XK, Shi Y, Song Y: TLR4 is Essential in Acute Lung
Injury Induced by Unresuscitated Hemorrhagic Shock.  Jour-
nal of Trauma-Injury Infection and Critical Care 2009, 66(1):124-131.
24. Kajikawa O, Frevert CW, Lin SM, Goodman RB, Mongovin SM, Wong
V, Ballman K, Daubeuf B, Elson G, Martin TR: Gene expression of
Toll-like receptor-2, Toll-like receptor-4, and MD2 is differ-
entially regulated in rabbits with Escherichia coli pneumo-
nia.  Gene 2005, 344:193-202.
25. Abel B, Thieblemont N, Quesniaux VJ, Brown N, Mpagi J, Miyake K,
Bihl F, Ryffel B: Toll-like receptor 4 expression is required to
control chronic Mycobacterium tuberculosis infection in
mice.  J Immunol 2002, 169(6):3155-3162.
26. Scaffidi AK, Moodley YP, Weichselbaum M, Thompson PJ, Knight DA:
Regulation of human lung fibroblast phenotype and functionPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Respiratory Research 2009, 10:126 http://respiratory-research.com/content/10/1/126
Page 10 of 10
(page number not for citation purposes)
by vitronectin and vitronectin integrins.  Journal of cell science
2001, 114(Pt 19):3507-3516.
27. White ES, Thannickal VJ, Carskadon SL, Dickie EG, Livant DL, Mark-
wart S, Toews GB, Arenberg DA: Integrin alpha4beta1 regulates
migration across basement membranes by lung fibroblasts:
a role for phosphatase and tensin homologue deleted on
chromosome 10.  American journal of respiratory and critical care med-
icine 2003, 168(4):436-442.
28. Chetty A, Cao GJ, Nielsen HC: Insulin-like Growth Factor-I sig-
naling mechanisms, type I collagen and alpha smooth muscle
actin in human fetal lung fibroblasts.  Pediatric research 2006,
60(4):389-394.
29. Kang HR, Lee CG, Homer RJ, Elias JA: Semaphorin 7A plays a
critical role in TGF-beta1-induced pulmonary fibrosis.  The
Journal of experimental medicine 2007, 204(5):1083-1093.
30. Ricupero DA, Poliks CF, Rishikof DC, Cuttle KA, Kuang PP, Goldstein
RH: Phosphatidylinositol 3-kinase-dependent stabilization of
alpha1(I) collagen mRNA in human lung fibroblasts.  American
journal of physiology 2001, 281(1):C99-C105.
31. Xu SW, Chen Y, Denton CP, Eastwood M, Renzoni EA, Bou-Gharios
G, Pearson JD, Dashwood M, du Bois RM, Black CM, et al.: Endothe-
lin-1 promotes myofibroblast induction through the ETA
receptor via a rac/phosphoinositide 3-kinase/Akt-dependent
pathway and is essential for the enhanced contractile pheno-
type of fibrotic fibroblasts.  Molecular biology of the cell 2004,
15(6):2707-2719.
32. Utsugi M, Dobashi K, Ishizuka T, Masubuchi K, Shimizu Y, Nakazawa
T, Mori M: C-Jun-NH2-terminal kinase mediates expression of
connective tissue growth factor induced by transforming
growth factor-beta1 in human lung fibroblasts.  American jour-
nal of respiratory cell and molecular biology 2003, 28(6):754-761.
33. Branger J, Knapp S, Weijer S, Leemans JC, Pater JM, Speelman P,
Florquin S, Poll T van der: Role of Toll-like receptor 4 in gram-
positive and gram-negative pneumonia in mice.  Infection and
immunity 2004, 72(2):788-794.
34. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascaren-
has MM, Garg HG, Quinn DA, et al.: Regulation of lung injury and
repair by Toll-like receptors and hyaluronan.  Nature medicine
2005, 11(11):1173-1179.